MEMANTINE FOR THE TREATMENT OF MILD AND MILD-TO-MODERATE ALZHEIMER'S DISEASE

摘要

The present invention provides a method for the treatment, prevention, or delay of progression of mild, or mild-to-moderate Alzheimer's disease, by administering an effective dose of memantine. The present invention also provides a method for preventing the decrease in glucose metabolism in the cortical and sub-cortical regions of the brain in subjectes with mild, or mild-to-moderate Alzheimer's disease.